An observational study of tasimelteon [HETLIOZ] in patients with Smith-Magenis Syndrome

Trial Profile

An observational study of tasimelteon [HETLIOZ] in patients with Smith-Magenis Syndrome

Recruiting
Phase of Trial: Phase II

Latest Information Update: 26 Feb 2015

At a glance

  • Drugs Tasimelteon (Primary)
  • Indications Developmental disabilities; Sleep disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Feb 2015 New trial record
    • 19 Feb 2015 According to media release, results of this trial are expected in first half of 2015.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top